| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |